NantCell

Settlement set to sling Soon-Shiong out of biotech investment
Fierce Biotech
Mon, 04/1/19 - 09:39 pm
Patrick Soon-Shiong
Precision Biologics
NantCell
Celgene invested $30M in NantCell weeks before BMS bid
BioCentury
Tue, 01/8/19 - 12:41 am
Celgene
NantCell
Bristol-Myers Squibb
M&A
Biotech billionaire Soon-Shiong picks up rights to CytRx’s troubled cancer drug
Endpoints
Fri, 07/28/17 - 11:33 am
biotech
Dr. Patrick Soon-Shiong
CytRx
NantCell
NantWorks
doxorubicin
soft tissue sarcoma